Price $336.85 |
Market Cap
105.67B
|
Sector Health Care |
Div. Growth
8.50%
|
|
P/E
41.0
|
P/B
6.04
|
P/S
5.27
|
Dividend %
1.10%
|
|
P/CF
294.0
|
P/FCF
79.9
|
Op. Cash Flow
3.03M
|
FCF
3.4
|
|
Op. Margin
16.70%
|
Net Margin
13.60%
|
ROE
16.10%
|
ROI
8.50%
|
|
ROA
7.40%
|
EPS Growth
29.90%
|
Current Ratio
1.6
|
Debt/Equity
71.40%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Cumberland Pharmaceuticals, In (CPIX) | $1.61 | - | - | 28.7M | Strong Buy |
| Interpace Biosciences Inc (IDXG) | $1.55 | - | - | 4.1M | Strong Buy |
| Jazz Pharmaceuticals PLC (JAZZ) | $108.32 | - | - | 8.13B | Strong Buy |
| Journey Medical Corp (DERM) | $3.40 | - | - | 43.3M | Strong Buy |
| KORU Medical Systems Inc (KRMD) | $2.20 | - | - | 103.6M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
